| Clinical phase |
Target cells |
Vector |
Gene |
ClinicalTrials.gov identifier |
| I |
Patient's T cells |
Not specified |
Anti-CEA Ig |
NCT00004178 |
| II |
Patient's T cells |
Not specified |
Anti-mesothelin |
NCT01583686 |
| Not specified |
Tumor cells |
HSV |
GM-CSF |
NCT00402025 |
| I |
Tumor cells |
Plasmid DNA + PEI |
SST2R+ DCK + UMK |
NCT01274455 |
| I/II |
Tumor cells |
Adenovirus |
Thymidine kinase |
NCT00638612 |
SST2R: Somatostatin receptor subtype 2; DCK: deoxycitidine kinase; UMK: uridylmonophosphaste kinase; PEI: polyethylenimine |
